Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Wang, Luqiang
134  Ergebnisse:
Personensuche X
?
1

Three-band triangular linearly frequency-modulated continuo..:

Chen, Shilin ; Pu, Tao ; Zheng, Jilin...
Optical and Quantum Electronics.  56 (2024)  7 - p. , 2024
Link: https://doi.org/10.1007/..
 
?
2

POSTER: ABCL-515 Updated Results of the Safety Run-In of th..:

Kwiatek, Michal ; Grosicki, Sebastian ; Jiménez, Javier López...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S204 , 2023
Link: https://doi.org/10.1016/..
 
?
3

P1132: LONG-TERM RESPONSES WITH LONCASTUXIMAB TESIRINE: UPD..:

Caimi, Paolo F ; Ai, Weiyun Z ; Pablo Alderuccio, Juan...
HemaSphere.  7 (2023)  S3 - p. e402511c , 2023
Link: https://doi.org/10.1097/..
 
?
4

ABCL-515 Updated Results of the Safety Run-In of the Phase ..:

Kwiatek, Michal ; Grosicki, Sebastian ; Jiménez, Javier López...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S439-S440 , 2023
Link: https://doi.org/10.1016/..
 
?
5

Loncastuximab tesirine in relapsed/refractory diffuse large..:

Caimi, Paolo F. ; Ai, Weiyun Z. ; Alderuccio, Juan Pablo...
Haematologica.  , 2023
Link: https://doi.org/10.3324/..
 
?
6

Activin A marks a novel progenitor cell population during f..:

Yao, Lutian ; Lu, Jiawei ; Zhong, Leilei...
eLife.  12 (2023)  - p. , 2023
Link: https://doi.org/10.7554/..
 
?
7

Risk factors for pulmonary cement embolism after percutaneo..:

Wang, Luqiang ; Lu, Ming ; Zhang, Xinxin...
Frontiers in Oncology.  13 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
8

Melanoma Molecular Subtypes and Development of Prognostic a..:

Xu, Libin ; Zhang, Yu ; Liu, Ting...
Computational and Mathematical Methods in Medicine.  2022 (2022)  - p. 1-28 , 2022
Link: https://doi.org/10.1155/..
 
?
9

Poster: HL-339 Camidanlumab Tesirine: Updated Efficacy and ..:

Carlo-Stella, Carmelo ; Ansell, Stephen ; Zinzani, Pier Luigi...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S162 , 2022
Link: https://doi.org/10.1016/..
 
?
10

ABCL-320 Initial Safety Run-In Results of the Phase 3 LOTIS..:

Kingsley, Edwin ; Grosicki, Sebastian ; Kwiatek, Michal...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S372 , 2022
Link: https://doi.org/10.1016/..
 
?
11

MiR-21 participates in LPS-induced myocardial injury by tar..:

Li, Yu ; Sun, Guanghui ; Wang, Luqiang
Inflammation Research.  71 (2022)  2 - p. 205-214 , 2022
Link: https://doi.org/10.1007/..
 
?
12

Oral Abstract: HL-339 Camidanlumab Tesirine: Updated Effica..:

Carlo-Stella, Carmelo ; Ansell, Stephen ; Zinzani, Pier Luigi...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S118 , 2022
Link: https://doi.org/10.1016/..
 
?
13

HL-339 Camidanlumab Tesirine: Updated Efficacy and Safety i..:

Carlo-Stella, Carmelo ; Ansell, Stephen ; Zinzani, Pier Luigi...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S347 , 2022
Link: https://doi.org/10.1016/..
 
?
14

Poster: ABCL-320 Initial Safety Run-In Results of the Phase..:

Kingsley, Edwin ; Grosicki, Sebastian ; Kwiatek, Michal...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S163 , 2022
Link: https://doi.org/10.1016/..
 
?
15

Health-Related Quality of Life, Symptoms, and Tolerability ..:

Spira, Alexander ; Zhou, Xiaolei ; Chen, Lei...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  3 - p. 158-168 , 2022
Link: https://doi.org/10.1016/..
 
1-15